Evidence map›Paper›PMID 41614153›Full record

ArticleJACS Au2026

Presentation Is Essential for Glycan-Lectin Recognition at the Molecular and Cellular Levels: The Interaction of Tumor-Associated

Ana Sofia Grosso, Ana Diniz, Cátia O Soares, Felix Goerdeler, Ana Gimeno, Pedro Coelho, Helena Coelho, Carlos D L Lima, Benedita Pinheiro, Marta G Lete and 12 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JACS Au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Ana Sofia GrossoUCIBIO - Applied Molecular Biosciences Unit, Department of Chemistry, NOVA School of Science and Technology, NOVA University Lisbon, 2829-516 Caparica, Portugal.
Ana DinizUCIBIO - Applied Molecular Biosciences Unit, Department of Chemistry, NOVA School of Science and Technology, NOVA University Lisbon, 2829-516 Caparica, Portugal.
Cátia O SoaresUCIBIO - Applied Molecular Biosciences Unit, Department of Chemistry, NOVA School of Science and Technology, NOVA University Lisbon, 2829-516 Caparica, Portugal.
Felix GoerdelerCopenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, Faculty of Health Sciences, University of Copenhagen, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.ORCID https://orcid.org/0000-0002-7190-9145
Ana GimenoCIC bioGUNE, Basque Research and Technology Alliance, Bizkaia Technology Park, Ed. 800, E-48160 Derio, Spain.ORCID https://orcid.org/0000-0001-9668-2605
Pedro Coelhoi3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.
Helena CoelhoUCIBIO - Applied Molecular Biosciences Unit, Department of Chemistry, NOVA School of Science and Technology, NOVA University Lisbon, 2829-516 Caparica, Portugal.ORCID https://orcid.org/0000-0003-1992-8557
Carlos D L LimaUCIBIO - Applied Molecular Biosciences Unit, Department of Chemistry, NOVA School of Science and Technology, NOVA University Lisbon, 2829-516 Caparica, Portugal.
Benedita PinheiroUCIBIO - Applied Molecular Biosciences Unit, Department of Chemistry, NOVA School of Science and Technology, NOVA University Lisbon, 2829-516 Caparica, Portugal.
Marta G LeteCIC bioGUNE, Basque Research and Technology Alliance, Bizkaia Technology Park, Ed. 800, E-48160 Derio, Spain.
Fayna Garcia-MartinDepartamento de Química, Instituto de Investigación en Química de la Universidad de La Rioja (IQUR), Universidad de La Rioja, 26006 Logroño (La Rioja), Spain.
Thapakorn JaroentomeechaiCopenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, Faculty of Health Sciences, University of Copenhagen, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.
Joana Gomesi3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.
Celso A Reisi3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.
Ulrika WesterlindDepartment of Chemistry, Umeå University, 901 87 Umeå, Sweden.
Francisco CorzanaDepartamento de Química, Instituto de Investigación en Química de la Universidad de La Rioja (IQUR), Universidad de La Rioja, 26006 Logroño (La Rioja), Spain.ORCID https://orcid.org/0000-0001-5597-8127
Angelina S PalmaUCIBIO - Applied Molecular Biosciences Unit, Department of Chemistry, NOVA School of Science and Technology, NOVA University Lisbon, 2829-516 Caparica, Portugal.
Henrik ClausenCopenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, Faculty of Health Sciences, University of Copenhagen, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.
Jesús Jiménez-BarberoCIC bioGUNE, Basque Research and Technology Alliance, Bizkaia Technology Park, Ed. 800, E-48160 Derio, Spain.ORCID https://orcid.org/0000-0001-5421-8513
Sandra J van VlietDepartment of Molecular Cell Biology and Immunology, Amsterdam UMC location Vrije Universiteit Amsterdam, Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
Yoshiki NarimatsuCopenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, Faculty of Health Sciences, University of Copenhagen, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.
Filipa MarceloUCIBIO - Applied Molecular Biosciences Unit, Department of Chemistry, NOVA School of Science and Technology, NOVA University Lisbon, 2829-516 Caparica, Portugal.ORCID https://orcid.org/0000-0001-5049-8511

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human macrophage galactose-type lectin (MGL) recognizes exposed GalNAc residues abundantly found in tumor

Indexed as

glycan and receptor presentationmacrophage galactose-type lectinmolecular recognitiontumor-associated O-glycans

Identifiers

PMID41614153
PMCPMC12848722

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.